Equities: Trading in Affärsstrategerna AB ser. B excluding the Innate Pharmaceuticals AB and AlphaHelix Molecular Diagnostics AB dividend (108/07)

As from May 10th  2007, Affärsstrategerna AB ser. B will be traded excluding the Innate Pharmaceuticals AB and AlphaHelix Molecular Diagnostics AB dividend.

Terms: One share in Innate Pharmaceuticals AB will be received for every fiftieth ser. B share in Affärsstrategerna AB ser. B and one share in AlphaHelix Molecular Diagnostics AB will be received for every hundredth share in Affärsstrategerna AB ser. B
Unchanged round lot:	5 000

Notice! This requires consent from the Annual General Meeting on May 9th, 2007.